INHIBITORS OF SARM1 IN COMBINATION WITH NEUROPROTECTIVE AGENTS

The present disclosure relates to methods of treating neurodegeneration and neurodegenerative diseases comprising administering to a subject in need thereof a combination of a SARM1 inhibitor and a neuroprotective agent. La présente invention concerne des méthodes de traitement de la neurodégénéresc...

Full description

Saved in:
Bibliographic Details
Main Authors ENGBER, THOMAS, BOSANAC, TODD, DEVRAJ, RAJESH, HUGHES, ROBERT OWEN, KRAUSS, RAUL EDUARDO
Format Patent
LanguageEnglish
French
Published 02.04.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to methods of treating neurodegeneration and neurodegenerative diseases comprising administering to a subject in need thereof a combination of a SARM1 inhibitor and a neuroprotective agent. La présente invention concerne des méthodes de traitement de la neurodégénérescence et de maladies neurodégénératives qui consistent à administrer à un sujet qui en a besoin une combinaison d'un inhibiteur de SARM1 et d'un agent neuroprotecteur.
Bibliography:Application Number: CA20193123215